Fig. 1From: Can BNP-guided therapy improve health-related quality of life, and do responders to BNP-guided heart failure treatment have improved health-related quality of life? Results from the UPSTEP studyFlow chart of the patients in the UPSTEP-study. Conventionally treated (CTR group) and BNP group, BNP group divided into responders and non-responders. Responder defined as a patient with a BNP under 300 ng/l and/or a decrease in BNP of at least 40 percent in week 16 of follow-up, compared to study startBack to article page